Atrys Health, S.A. (A2T.F)

2.7200 +0.0600 (+2.26%) At close: 03:29PM CEST

Atrys Health, S.A.

Calle VelAzquez, 24
4th Floor Right
Madrid 28001
Spain

https://www.atryshealth.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 1,669

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Santiago De Torres Sanahuja	Executive Chairman	N/A	N/A	N/A
Ms. Isabel Lozano Fernandez	CEO & Executive Director	N/A	N/A	N/A
Dr. Carlos Cordon-Cardo	Founder & Scientific Vice President	N/A	N/A	N/A
Dr. Zvi Fuchs	Founder and Medical Vice President	N/A	N/A	N/A
Mr. Jose Maria Huch Ginesta	Chief Financial Officer	N/A	N/A	N/A
Luis Duran	Global Chief Technology Officer	N/A	N/A	N/A
Encarna Vega	Administration Director	N/A	N/A	N/A
Ms. Maria Marin	Head of Investor Relations	N/A	N/A	N/A
Ms. Gabriela Camunas	General Counsel	N/A	N/A	N/A
Pedro Salord	People Director	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. The company was incorporated in 2007 and is headquartered in Madrid, Spain.

Corporate governance

Atrys Health, S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.